Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kewei Chen

Showing results (481-490 of 511) with videos related to

Pageof 52
Sort By:
Journal of Alzheimer'S Disease : JAD|October 9, 2010
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's diseaseSofia Tzimopoulou, Vincent J Cunningham, Thomas E Nichols, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 6, 2023
Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's diseaseClara Vila-Castelar, Yinghua Chen, Stephanie Langella, et al.
The Lancet. Neurology|November 10, 2012
Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional studyAdam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Journal of Neuropathology and Experimental Neurology|June 15, 2016
Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and CognitionJessica R Filon, Anthony J Intorcia, Lucia I Sue, et al.
JAMA Neurology|June 30, 2015
Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional StudyYakeel T Quiroz, Aaron P Schultz, Kewei Chen, et al.
Alzheimer'S Research & Therapy|September 15, 2020
A phase II randomized trial of sodium oligomannate in Alzheimer's dementiaTao Wang, Weihong Kuang, Wei Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 16, 2026
Brain regional susceptibility to tauopathy in individuals at risk for chronic traumatic encephalopathyTim L T Wiegand, Anna Rubinski, Leonard B Jung, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 14, 2022
A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease TrialEric M Reiman, Jeremy J Pruzin, Silvia Rios-Romenets, et al.
Fluids and Barriers of the CNS|April 2, 2024
[1-<sup>11</sup>C]-Butanol Positron Emission Tomography reveals an impaired brain to nasal turbinates pathway in aging amyloid positive subjectsNeel H Mehta, Xiuyuan Wang, Samantha A Keil, et al.
The Lancet. Neurology|November 10, 2012
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control studyEric M Reiman, Yakeel T Quiroz, Adam S Fleisher, et al.
Pageof 52

Showing results (481-490 of 511) with videos related to

Sort By:
Pageof 52
Journal of Alzheimer'S Disease : JAD|October 9, 2010
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's diseaseSofia Tzimopoulou, Vincent J Cunningham, Thomas E Nichols, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 6, 2023
Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's diseaseClara Vila-Castelar, Yinghua Chen, Stephanie Langella, et al.
The Lancet. Neurology|November 10, 2012
Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional studyAdam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Journal of Neuropathology and Experimental Neurology|June 15, 2016
Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and CognitionJessica R Filon, Anthony J Intorcia, Lucia I Sue, et al.
JAMA Neurology|June 30, 2015
Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional StudyYakeel T Quiroz, Aaron P Schultz, Kewei Chen, et al.
Alzheimer'S Research & Therapy|September 15, 2020
A phase II randomized trial of sodium oligomannate in Alzheimer's dementiaTao Wang, Weihong Kuang, Wei Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 16, 2026
Brain regional susceptibility to tauopathy in individuals at risk for chronic traumatic encephalopathyTim L T Wiegand, Anna Rubinski, Leonard B Jung, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 14, 2022
A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease TrialEric M Reiman, Jeremy J Pruzin, Silvia Rios-Romenets, et al.
Fluids and Barriers of the CNS|April 2, 2024
[1-<sup>11</sup>C]-Butanol Positron Emission Tomography reveals an impaired brain to nasal turbinates pathway in aging amyloid positive subjectsNeel H Mehta, Xiuyuan Wang, Samantha A Keil, et al.
The Lancet. Neurology|November 10, 2012
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control studyEric M Reiman, Yakeel T Quiroz, Adam S Fleisher, et al.
Pageof 52